Metastatic Colorectal Cancers Unknown Status Phase 2 Trials for Labetuzumab govitecan (DB12331)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01915472A Phase II Study of IMMU 130 in Patients With Metastatic Colorectal CancerTreatment